Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

25 Sep 2020 13:02

RNS Number : 1802A
Collagen Solutions PLC
25 September 2020
 

 

 

Collagen Solutions plc

("Collagen" or the "Company")

 

Notice of AGM

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it is today posting a circular (the "Circular") to shareholders containing the notice of Annual General Meeting ("AGM").

 

The AGM will be held at the Company's offices at 3 Robroyston Oval, Nova Business Park, Glasgow G33 1AP at 11.00 a.m. (UK time) on 23 October 2020, however, as a result of the current COVID-19 pandemic and the legislative measures and associated guidance introduced by the UK and Scottish Governments in response, for the safety of our Shareholders, our employees, our advisers and the general public, the AGM will be held as a closed meeting.

 

Attendance by Shareholders at the AGM in person will not be possible and Shareholders or their appointed proxies (other than the chairman of the AGM) will not be permitted entry to the AGM. Further information on the arrangements for the AGM are set out in the Circular.

 

In the light of these measures the Directors of the Company strongly encourage shareholders to vote by proxy on all of the matters of business by appointing the Chairman of the Meeting as their proxy by submitting a proxy appointment in accordance with the instructions in the Circular and the proxy form.

 

Offer by Rosen's Diversified, Inc

On 27 August 2020, the Boards of Directors of the Company and Rosen's Diversified, Inc ("RDI") announced that agreement had been reached on the terms of a recommended cash offer by RDI for the entire issued and to be issued share capital of the Company not already owned by RDI (the "Offer"). The offer document containing the full terms and conditions of the Offer and the related form of acceptance were published on 14 September 2020.

 

The AGM is being convened in view of the Company's obligations under the Companies Act 2006. Whether or not you have accepted or intend to accept the Offer, you are still entitled to vote at the AGM, provided that you remain on the register of members of the Company at the relevant time. Where you have accepted the Offer before the AGM, your vote at the AGM will still be counted if: (i) you have followed the instructions set out in the notice of AGM and (where applicable) the accompanying form of proxy; and (ii) you are registered in the register of members of the Company at close of trading on 21 October 2020 (or, in the event of any adjournment of the AGM, on the date which is two days before the time of the adjourned meeting). Changes to the register of members after the relevant deadline, whether as a result of acceptance of the Offer or otherwise, shall be disregarded in determining the rights of any person to vote at the meeting.

 

Annual report and accounts for the year ended 31 March 2020

On 31 July 2020, the Company announced its unaudited results for the year ended 31 March 2020. The Company had previously announced on 15 June 2020 that it had been granted an extension to the filing deadline for its audited consolidated accounts for the year ended 31 March 2020 to 31 December 2020 in light of the ongoing COVID-19 pandemic. Accordingly, the audited consolidated accounts for the year ended 31 March 2020 and the directors' reports thereon are not enclosed with the Circular and will not be laid before the AGM.

 

Collagen Solutions Plc

Via Walbrook

Jamal Rushdy, CEO

Hilary Spence, CFO

Cenkos Securities Plc (Nominated Adviser and Broker)

Giles Balleny (Corporate Finance)

Tel: 0207 397 8900

Stephen Keys

Walbrook PR Ltd

Tel: 020 7933 8780 or collagen@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAEAANSAEEEEFA
Date   Source Headline
12th Sep 20167:00 amRNSIssue of Equity
24th Aug 201611:26 amRNSResult of AGM
25th Jul 201611:48 amRNSPosting of Annual Report
19th Jul 20167:15 amRNSHardman research: Focused scalable growth
15th Jul 20167:00 amRNSGrant of Options
12th Jul 20165:12 pmRNSDirector/PDMR Shareholding
12th Jul 201611:51 amRNSHolding(s) in Company
11th Jul 20164:15 pmRNSDirector/PDMR Shareholding
11th Jul 20163:16 pmRNSDirector/PDMR Shareholding
11th Jul 20167:00 amRNSFinal Results
13th Jun 20167:00 amRNSNotice of Results Investor Presentation
4th May 20167:00 amRNSDirectorate Change
3rd May 20167:00 amRNSLeadership changes and preliminary FY revenue
27th Apr 20165:34 pmRNSHolding(s) in Company
26th Apr 20168:28 amRNSJoint Venture Agreement in China
19th Apr 20167:00 amRNSSupply of collagen materials to Merck
30th Mar 20169:37 amRNSHolding(s) in Company
23rd Mar 20167:00 amRNSResearch collaboration
26th Feb 20161:02 pmRNSHolding(s) in Company
12th Feb 20167:00 amRNSDeath of adviser
3rd Feb 20167:00 amRNSCollagen Solutions present at The Scotsman
22nd Jan 20165:47 pmRNSHolding(s) in Company
21st Jan 201610:14 amRNSChairman's Share Purchase
20th Jan 20167:00 amRNSTrading Update
14th Jan 20165:29 pmRNSHolding(s) in Company
9th Dec 201511:17 amRNSHolding(s) in Company
9th Dec 20157:00 amRNSHardman Issues Research Report
7th Dec 20157:00 amRNSCollagen Solutions Supply Agreement with BBI
2nd Dec 20153:48 pmRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSHalf Yearly Report
20th Nov 20153:20 pmRNSDeath of a Director
18th Nov 20157:00 amRNSAppointment of Chief Business Officer
3rd Nov 20157:00 amRNSNotice of Results
28th Sep 20157:00 amRNSCollagen supply agreement to Yucel Medical
22nd Sep 20157:00 amRNSMedical Research Studentship
16th Sep 20157:00 amRNSSupply Agreement with Histogenics Corporation
14th Sep 20157:00 amRNSAcquisition of a regenerative medicine product
3rd Sep 20157:00 amRNSFDA approval for NovaBone product
28th Aug 201510:11 amRNSAGM Statement
28th Aug 20157:00 amRNSJoins consortium developing new treatments
22nd Jul 20157:00 amRNSPosting of Annual Report & Notice of AGM
15th Jul 201510:09 amRNSHardman & Co issues research on Collagen Solutions
14th Jul 20157:00 amRNSPartnership with UCL and Oxford MEStar Ltd
13th Jul 20157:00 amRNSFinal Results
3rd Jul 20152:11 pmRNSNotice of Results
26th Jun 20157:00 amRNSChange of Adviser
22nd Jun 20157:00 amRNSInnovate UK Grant Award
28th May 20157:00 amRNSNew Patent Granted
17th Apr 20151:53 pmRNSHardman & Co issues research report
14th Apr 20157:00 amRNSUK Investor Show attendance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.